Monoclonal Antibody Therapeutics: Transforming the Landscape of Chronic Disease Treatment Innovative Approaches and Advancements
Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as clone copies of a single parent cell. They can be designed to bind to specific proteins, known as antigens, on pathogens or cancerous/damaged cells. Since their discovery in 1975, monoclonal antibodies have revolutionized both research and clinical practice.Production of Monoclonal Antibody Therapeutics The...
0 Commentaires 0 Parts 602 Vue 0 Aperçu
Commandité